Revenue grew 12.9% YoY to ₹4,031 Cr in Q1 FY27, with EBITDA margin up 250 bps to 26.3% and PAT up 29.1%. Domestic and export businesses posted double-digit growth, while Consumer Healthcare gained market share in key brands.Original document: Mankind Pharma Ltd. [MANKIND] Slides Release — Jul. 30 2…
Revenue grew 12.9% YoY to ₹4,031 Cr in Q1 FY27, with EBITDA margin up 250 bps to 26.3% and PAT up 29.1%. Domestic and export businesses posted double-digit growth, while Consumer Healthcare gained market share in key brands.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.